The Knowledge Congress Has Scheduled a Live Webcast on Legal Series: Understanding FDA’s Consent Form Requirements Live Webcast
New York, NY, November 24, 2012 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, brings together the world's leading authorities and industry participants through informative two-hour webcasts.
It has scheduled a live webcast entitled: “Legal Series: Understanding FDA’s Consent Form Requirements Live Webcast.” This two-hour event is scheduled on January 17, 2013 from 12:00 PM to 2:00 PM ET.
Event Synopsis:
The Food and Drug Administration issued a new consent form requirement for FDA-regulated clinical trials effective this March 7, 2012. Consent forms of drugs, biological products or devices that are subject to FDA regulation are required to contain certain specific statements provided by the FDA. The statement is Applicable to clinical trials initiated on or after March 7, 2012, the statements are intended to advise the participants that the clinical trial information is available on the ClinicalTrials.gov database. The question now is how should the industry comply in a cost effective manner that does not compromise the integrity of the science.
Speakers/Faculty Panel
Harry Nelson, Co-Founder, Fenton Nelson
Lisa Murtha, Esq., Partner, SNR Denton US LLP
For further details about this event, please visit:
http://www.knowledgecongress.org/event_2012_Consent_Form.html
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries.
Contact information:
The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
http://www.knowledgecongress.org
info@knowledgecongress.org
It has scheduled a live webcast entitled: “Legal Series: Understanding FDA’s Consent Form Requirements Live Webcast.” This two-hour event is scheduled on January 17, 2013 from 12:00 PM to 2:00 PM ET.
Event Synopsis:
The Food and Drug Administration issued a new consent form requirement for FDA-regulated clinical trials effective this March 7, 2012. Consent forms of drugs, biological products or devices that are subject to FDA regulation are required to contain certain specific statements provided by the FDA. The statement is Applicable to clinical trials initiated on or after March 7, 2012, the statements are intended to advise the participants that the clinical trial information is available on the ClinicalTrials.gov database. The question now is how should the industry comply in a cost effective manner that does not compromise the integrity of the science.
Speakers/Faculty Panel
Harry Nelson, Co-Founder, Fenton Nelson
Lisa Murtha, Esq., Partner, SNR Denton US LLP
For further details about this event, please visit:
http://www.knowledgecongress.org/event_2012_Consent_Form.html
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries.
Contact information:
The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
http://www.knowledgecongress.org
info@knowledgecongress.org
Contact
The Knowledge Congress
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Categories